Avid Bioservices Inc (CDMO)

[entdoc]

eb0783 you are welcome to stay out of "any long drawn out speculation" about chimeric vs. humanized Bavi, but the fact that Thorpe said humanized is not necessarily better relates only to the intended application of the technology. There is no long drawn out speculation about which form of Bavi is better at exciting a body's immune response. That's a given. Thorpe gave us that. Now the question is, which form of Bavi is better at flying in under the radar (body immune response) to deliver a payload...and why would Genentec be looking at fully humanized Bavi otherwise. Two different applications. The point is that chimeric Bavi is an infantile form of the anti-PS agent which will be used a decade from now. That meaning the anti-PS platform is worth an incredible amount more $$$ than naked, chimeric Bavi battling against end-stage lung and pancreatic cancer.